Skip to main content
logo
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.8481
-0.0113 (-1.31%)
At close: May 19, 2026, 4:00 PM EDT
0.8568
+0.0087 (1.03%)
After-hours: May 19, 2026, 7:02 PM EDT

Heron Therapeutics Revenue

Heron Therapeutics had revenue of $34.71M in the quarter ending March 31, 2026, a decrease of -10.78%. This brings the company's revenue in the last twelve months to $150.71M, up 1.48% year-over-year. In the year 2025, Heron Therapeutics had annual revenue of $154.90M with 7.36% growth.

Revenue (ttm)
$150.71M
Revenue Growth
+1.48%
P/S Ratio
1.07
Revenue / Employee
$1,177,438
Employees
128
Market Cap
160.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025154.90M10.62M7.36%
Dec 31, 2024144.29M17.24M13.57%
Dec 31, 2023127.04M19.37M17.99%
Dec 31, 2022107.67M21.33M24.70%
Dec 31, 202186.35M-2.29M-2.59%
Dec 31, 202088.64M-57.33M-39.28%
Dec 31, 2019145.97M68.49M88.41%
Dec 31, 201877.47M46.71M151.81%
Dec 31, 201730.77M29.49M2,305.55%
Dec 31, 20161.28M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011646.00K-655.00K-50.35%
Dec 31, 20101.30M40.00K3.17%
Dec 31, 20091.26M892.00K241.73%
Dec 31, 2008369.00K-43.00K-10.44%
Dec 31, 2007412.00K--
Dec 31, 2006---
Dec 31, 20055.39M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

HRTX News

More News